From the Division of Plastic and Reconstructive Surgery, Massachusetts General Hospital, Harvard Medical School.
Division of Plastic and Reconstructive Surgery, Brigham and Women's Hospital, Harvard Medical School.
Plast Reconstr Surg. 2023 Nov 1;152(5):1118-1124. doi: 10.1097/PRS.0000000000010403. Epub 2023 Mar 14.
Microsurgical free tissue transfer may be the only reconstructive option for lower extremity limb salvage. However, the functional and aesthetic results following free tissue transfer after initial salvage may be suboptimal, thus requiring secondary operations to facilitate definitive wound healing and/or refinement.
A multi-institutional retrospective cohort study was performed including patients who underwent lower extremity free tissue transfer from January of 2002 to December of 2020. The authors' primary outcome variable was the presence of secondary surgery after free tissue transfer for lower extremity reconstruction. Independent variables (eg, wound cause, flap, donor type, recipient, comorbidities) were collected. Secondary surgery was categorized as (1) procedures for definitive wound closure and (2) refinement procedures. Multivariable logistic regression was performed to determine which variables were independently associated with the outcome.
A total of 420 free tissue transfers for lower extremity reconstruction were identified. Secondary surgery was performed in over half (57%) of the patients. Presence of diabetes (OR, 2.0; P = 0.01; 95% CI, 1.2 to 3.5) and use of a latissimus dorsi donor (OR, 2.4; P = 0.037; 95% CI, 1.1 to 5.4) were predictors of wound closure procedures. Fasciocutaneous (OR, 3.6; P < 0.001; 95% CI, 1.8 to 7.2) and myocutaneous (OR, 3.0; P = 0.005; 95% CI, 1.5 to 9.9) flaps were predictors of refinement procedures when compared with muscle-only flaps with skin grafts.
The majority of lower extremity free tissue reconstructions required secondary procedures to provide definitive wound closure and/or refinement. Overall, this study provides predictors of secondary surgery that will help formulate patients' expectations of lower extremity limb salvage.
CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.
显微游离组织移植可能是下肢保肢的唯一重建选择。然而,游离组织移植后最初的保肢治疗的功能和美学效果可能并不理想,因此需要进行二次手术以促进确定性伤口愈合和/或改善。
进行了一项多机构回顾性队列研究,纳入了 2002 年 1 月至 2020 年 12 月期间接受下肢游离组织移植的患者。作者的主要观察变量是游离组织移植后下肢重建的二次手术。收集了独立变量(例如,伤口原因、皮瓣、供区类型、受区、合并症)。二次手术分为(1)确定性伤口闭合的程序和(2)精细处理的程序。进行多变量逻辑回归以确定哪些变量与结果独立相关。
共确定了 420 例下肢重建游离组织转移。超过一半(57%)的患者接受了二次手术。存在糖尿病(比值比,2.0;P=0.01;95%可信区间,1.2 至 3.5)和使用背阔肌供区(比值比,2.4;P=0.037;95%可信区间,1.1 至 5.4)是伤口闭合手术的预测因素。筋膜皮瓣(比值比,3.6;P<0.001;95%可信区间,1.8 至 7.2)和肌皮瓣(比值比,3.0;P=0.005;95%可信区间,1.5 至 9.9)与仅带皮片的肌肉瓣相比,是精细处理程序的预测因素。
大多数下肢游离组织重建需要二次手术以提供确定性伤口闭合和/或精细处理。总的来说,本研究提供了二次手术的预测因素,这将有助于制定患者对下肢保肢的期望。
临床问题/证据水平:风险,III 级。